Tolvaptan therapy of Chinese cirrhotic patients with ascites after insufficient diuretic routine medication responses: a phase III clinical trial

BACKGROUND: To determine the safety and efficacy of different doses of tolvaptan for treating Chinese cirrhotic patients with or without hyponatraemia who still had ascites after routine therapy with diuretics. METHODS: In the present placebo-controlled, randomized, double-blinded, multicentre clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Jieting, Wang, Yongfeng, Han, Tao, Mao, Qing, Cheng, Jun, Ding, Huiguo, Shang, Jia, Zhang, Qin, Niu, Junqi, Ji, Feng, Chen, Chengwei, Jia, Jidong, Jiang, Xiangjun, Lv, Nonghua, Gao, Yueqiu, Wang, Zhenghua, Wei, Zhong, Chen, Yingxuan, Zeng, Minde, Mao, Yimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678173/
https://www.ncbi.nlm.nih.gov/pubmed/33213378
http://dx.doi.org/10.1186/s12876-020-01536-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678173/
https://www.ncbi.nlm.nih.gov/pubmed/33213378
http://dx.doi.org/10.1186/s12876-020-01536-0

Ejemplares similares